| T-cells engineered to kill leukemia cells. Complete remission in 2/3 patients. |
|
| LA Times: In early results from a clinical trial, genetically engineered T cells eradicate leukemia cells and thrive. Two of three patients studied have been cancer-free for more than a year. |